Answers are grounded in this paper and cite their sources.
Demonstrates identifying cardiovascular health trends in astronauts, indicating effective data methodology.
The National Aeronautics and Space Administration (NASA) Human Research Program collected data from the Artemis II four-person mission through three studies: the Artemis II Spaceflight Standard Measures study, the ARCHeR (Artemis Crew Health and Research) study, and the Immune Biomarkers study. These three studies presented a significant analytical challenge—extremely small sample size (n=<4); high dimensionality (p>>n); and “multiple physiological, behavioral, and operational data streams” (NASA Human Research Program & Floor23 Digital 2026c). In response, NASA sponsored and launched the NASA Artemis II Human Research Data Methodology Challenge under the America COMPETES Act on Monday, March 30, 2026, posing the question: “How do we extract the maximum possible scientific insight from data of this nature?” (NASA Human Research Program & Floor23 Digital 2026b). This paper posits linear regression analysis to be a feasible data methodology for identifying trends within Artemis II astronauts over time in support of astronaut health by demonstrating such a data methodology with longitudinal proxy data. More specifically, demonstrating linear regression analyses for identifying hematocrit and plasma percentage trends within astronaut-like individuals over time to support healthy cardiovascular physiology for astronauts by utilizing UTMB bedrest data from Campaign 3 (n=4, N=24) and Campaign 11 (n=4, N=37) is accomplished.
No takes yet. Share an insight, caveat, or question.
Patricia I. Cox (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: